These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26118669)

  • 1. Acarbose Monotherapy and Type 2 Diabetes Prevention in Eastern and Western Prediabetes: An Ethnicity-specific Meta-analysis.
    Hu R; Li Y; Lv Q; Wu T; Tong N
    Clin Ther; 2015 Aug; 37(8):1798-812. PubMed ID: 26118669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; De Grauw WJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005061. PubMed ID: 17054235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis.
    Zhu Q; Tong Y; Wu T; Li J; Tong N
    Clin Ther; 2013 Jun; 35(6):880-99. PubMed ID: 23602502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
    Gerstein HC; Coleman RL; Scott CAB; Xu S; Tuomilehto J; Rydén L; Holman RR;
    Diabetes Care; 2020 Sep; 43(9):2242-2247. PubMed ID: 32641379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy in prediabetes.
    Mukhopadhyay P; Chowdhury S
    J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials.
    Yuen A; Sugeng Y; Weiland TJ; Jelinek GA
    Aust N Z J Public Health; 2010 Apr; 34(2):172-8. PubMed ID: 23331362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
    Hanefeld M; Chiasson JL; Koehler C; Henkel E; Schaper F; Temelkova-Kurktschiev T
    Stroke; 2004 May; 35(5):1073-8. PubMed ID: 15073402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acarbose monotherapy and weight loss in Eastern and Western populations with hyperglycaemia: an ethnicity-specific meta-analysis.
    Li Y; Tong Y; Zhang Y; Huang L; Wu T; Tong N
    Int J Clin Pract; 2014 Nov; 68(11):1318-32. PubMed ID: 24853116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
    Hedrington MS; Davis SN
    Expert Opin Pharmacother; 2019 Dec; 20(18):2229-2235. PubMed ID: 31593486
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the metabolic syndrome patient with prediabetes be offered pharmacotherapy?
    Sullivan SD; Ratner RE
    Curr Diab Rep; 2011 Apr; 11(2):91-8. PubMed ID: 21207204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of acarbose and an Oroxylum indicum seed extract in streptozotocin and high-fat-diet induced prediabetic mice.
    Sun W; Sang Y; Zhang B; Yu X; Xu Q; Xiu Z; Dong Y
    Biomed Pharmacother; 2017 Mar; 87():160-170. PubMed ID: 28056420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.
    Hanefeld M
    Cardiovasc Diabetol; 2007 Aug; 6():20. PubMed ID: 17697384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
    Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
    Lancet; 2002 Jun; 359(9323):2072-7. PubMed ID: 12086760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acarbose on polycystic ovary syndrome: a meta-analysis.
    Zhang YY; Hou LQ; Zhao TY
    Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):373-8. PubMed ID: 24941435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediabetes: A pragmatic triage for preventive pharmacotherapy.
    Kalra S; Bhattacharya S; Sahay R
    J Pak Med Assoc; 2022 Feb; 72(2):369-372. PubMed ID: 35320197
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.